Manufacturer: Ipsen
Active Substance(s): BOTULINUM TOXIN TYPE A
Strength: 300u
Pack Size: 1 x 300u Vial
DYSPORT® 300u is an injectable neurotoxin formulation used to temporarily improve the appearance of moderate to severe frown lines between the eyebrows (glabellar lines) in adults. It works by blocking nerve signals to the muscles, which temporarily reduces muscle activity and smooths the skin. Dysport is made from botulinum toxin type A and is a clinically proven treatment with results that can last up to 4 months.
INFORMATION
DYSPORT® 300u – Key Features and Benefits
DYSPORT® 300 Units is a botulinum toxin type A product used for both aesthetic and therapeutic purposes. It works by blocking nerve signals to muscles, thereby reducing muscle contractions that cause wrinkles or spasticity.
-
Contains clostridium botulinum type A neurotoxin, from Hall strain
-
300 units per vial, in powder form for reconstitution
-
Onset of effect: within 2–3 days, peak at 1–2 weeks
-
Duration of action: up to 4 months
-
Used for glabellar lines, cervical dystonia, blepharospasm, and more
-
Proven efficacy and consistent dosing for repeat treatments
-
Similar indications to Botox®, but with a different unit equivalence
DYSPORT® 300u – Indications
DYSPORT® 300u is indicated for use in adults and children for several muscle-related conditions, including both medical and cosmetic uses.
-
Aesthetic indication:
-
Temporary improvement in moderate to severe glabellar lines
-
-
Therapeutic indications (adults):
-
Cervical dystonia (spasmodic torticollis)
-
Upper limb spasticity
-
Blepharospasm
-
-
Pediatric use:
-
Lower limb spasticity due to cerebral palsy (≥2 years old)
-
-
Always administered by a trained medical professional
DYSPORT® 300u – Ingredients
DYSPORT® contains botulinum toxin type A and stabilizers to maintain potency. The powder is white and must be reconstituted prior to use.
-
Active ingredient:
-
Clostridium botulinum toxin type A – 300 units per vial
-
-
Excipients:
-
Human albumin
-
Lactose monohydrate
-
-
Formulation:
-
Lyophilized powder for injection
-
-
Diluent:
-
0.9% sodium chloride (preservative-free) for reconstitution
-
DYSPORT® 300u – How To Use
DYSPORT® 300u must be reconstituted and administered by qualified professionals, with dosing adjusted based on indication, muscle mass, and individual response.
-
Route: Intramuscular injection
-
Dilution: Typically reconstituted with 1.5 to 2.5 mL of 0.9% NaCl
-
Injection technique:
-
Varies based on use (e.g., five-point injection for glabellar lines)
-
-
Onset: 2–3 days; peak effect in 1–2 weeks
-
Duration: 12–16 weeks (3–4 months)
-
Storage:
-
Store unopened vials refrigerated (2–8°C)
-
Use reconstituted solution within 24 hours
-
DYSPORT® 300u – Side Effects
DYSPORT® has a well-established safety profile, though some patients may experience localized or systemic reactions. Side effects vary by treatment area and dosage.
Common side effects (aesthetic use):
-
Headache
-
Eyelid drooping (ptosis)
-
Injection site discomfort
-
Dry eyes or tearing
Common side effects (therapeutic use):
-
Muscle weakness
-
Fatigue
-
Dysphagia (difficulty swallowing)
-
Flu-like symptoms
Rare but serious effects:
-
Allergic reactions (rash, itching, difficulty breathing)
-
Systemic botulinum toxin spread (e.g., difficulty swallowing or breathing)
-
Antibody formation (may reduce effectiveness)
DYSPORT® 300u – Clinical Studies
DYSPORT® has been extensively studied across multiple indications, with robust data supporting its efficacy and tolerability.
-
Glabellar line trials:
-
Showed significant wrinkle reduction compared to placebo
-
Improvement maintained for up to 4 months
-
-
Cervical dystonia:
-
Effective in reducing neck pain and muscle spasms
-
Repeated doses were safe and well tolerated
-
-
Pediatric lower limb spasticity:
-
Demonstrated improved gait pattern and spasticity control
-
No increase in adverse event frequency over multiple cycles
-
DYSPORT® 300u – Manufacturer Information
DYSPORT® is manufactured by Ipsen Biopharm Ltd., a global biopharmaceutical company specializing in neurology, oncology, and rare diseases.
-
Manufacturer: Ipsen Biopharm Ltd., Wrexham, UK
-
Brand owner: Ipsen Pharma, France
-
Marketed internationally under: DYSPORT®
-
Approved for use in over 70 countries
-
Distributed by licensed partners worldwide
-
Requires cold chain handling for stability
DYSPORT® 300u – FAQ (Based on Google SERP)
How many units of DYSPORT® equal Botox®?
The general conversion ratio is 2.5 to 3 units of DYSPORT® = 1 unit of Botox®, though this varies by use and patient.
How long does DYSPORT® last?
Results typically last 3 to 4 months, similar to Botox®.
When will I see results from DYSPORT®?
Most patients notice results within 2–3 days, with full effect in 7–14 days.
Can DYSPORT® be used for the same areas as Botox®?
Yes. It’s approved for glabellar lines, cervical dystonia, and other muscle conditions, often used as a Botox alternative.
Is DYSPORT® safe for long-term use?
Yes. Clinical data support safe repeated use with consistent efficacy over multiple injection cycles.
What’s the difference between DYSPORT® and Botox®?
DYSPORT® diffuses more broadly, which may benefit larger treatment areas. Botox® may stay more localized.
Can children receive DYSPORT®?
Yes, for specific conditions such as lower limb spasticity in cerebral palsy, for children aged 2 and older.
DYSPORT® 300u – Key Features and Benefits
DYSPORT® 300 Units is a botulinum toxin type A product used for both aesthetic and therapeutic purposes. It works by blocking nerve signals to muscles, thereby reducing muscle contractions that cause wrinkles or spasticity.
-
Contains clostridium botulinum type A neurotoxin, from Hall strain
-
300 units per vial, in powder form for reconstitution
-
Onset of effect: within 2–3 days, peak at 1–2 weeks
-
Duration of action: up to 4 months
-
Used for glabellar lines, cervical dystonia, blepharospasm, and more
-
Proven efficacy and consistent dosing for repeat treatments
-
Similar indications to Botox®, but with a different unit equivalence
DYSPORT® 300u – Indications
DYSPORT® 300u is indicated for use in adults and children for several muscle-related conditions, including both medical and cosmetic uses.
-
Aesthetic indication:
-
Temporary improvement in moderate to severe glabellar lines
-
-
Therapeutic indications (adults):
-
Cervical dystonia (spasmodic torticollis)
-
Upper limb spasticity
-
Blepharospasm
-
-
Pediatric use:
-
Lower limb spasticity due to cerebral palsy (≥2 years old)
-
-
Always administered by a trained medical professional
DYSPORT® 300u – Ingredients
DYSPORT® contains botulinum toxin type A and stabilizers to maintain potency. The powder is white and must be reconstituted prior to use.
-
Active ingredient:
-
Clostridium botulinum toxin type A – 300 units per vial
-
-
Excipients:
-
Human albumin
-
Lactose monohydrate
-
-
Formulation:
-
Lyophilized powder for injection
-
-
Diluent:
-
0.9% sodium chloride (preservative-free) for reconstitution
-
DYSPORT® 300u – How To Use
DYSPORT® 300u must be reconstituted and administered by qualified professionals, with dosing adjusted based on indication, muscle mass, and individual response.
-
Route: Intramuscular injection
-
Dilution: Typically reconstituted with 1.5 to 2.5 mL of 0.9% NaCl
-
Injection technique:
-
Varies based on use (e.g., five-point injection for glabellar lines)
-
-
Onset: 2–3 days; peak effect in 1–2 weeks
-
Duration: 12–16 weeks (3–4 months)
-
Storage:
-
Store unopened vials refrigerated (2–8°C)
-
Use reconstituted solution within 24 hours
-
DYSPORT® 300u – Side Effects
DYSPORT® has a well-established safety profile, though some patients may experience localized or systemic reactions. Side effects vary by treatment area and dosage.
Common side effects (aesthetic use):
-
Headache
-
Eyelid drooping (ptosis)
-
Injection site discomfort
-
Dry eyes or tearing
Common side effects (therapeutic use):
-
Muscle weakness
-
Fatigue
-
Dysphagia (difficulty swallowing)
-
Flu-like symptoms
Rare but serious effects:
-
Allergic reactions (rash, itching, difficulty breathing)
-
Systemic botulinum toxin spread (e.g., difficulty swallowing or breathing)
-
Antibody formation (may reduce effectiveness)
DYSPORT® 300u – Clinical Studies
DYSPORT® has been extensively studied across multiple indications, with robust data supporting its efficacy and tolerability.
-
Glabellar line trials:
-
Showed significant wrinkle reduction compared to placebo
-
Improvement maintained for up to 4 months
-
-
Cervical dystonia:
-
Effective in reducing neck pain and muscle spasms
-
Repeated doses were safe and well tolerated
-
-
Pediatric lower limb spasticity:
-
Demonstrated improved gait pattern and spasticity control
-
No increase in adverse event frequency over multiple cycles
-
DYSPORT® 300u – Manufacturer Information
DYSPORT® is manufactured by Ipsen Biopharm Ltd., a global biopharmaceutical company specializing in neurology, oncology, and rare diseases.
-
Manufacturer: Ipsen Biopharm Ltd., Wrexham, UK
-
Brand owner: Ipsen Pharma, France
-
Marketed internationally under: DYSPORT®
-
Approved for use in over 70 countries
-
Distributed by licensed partners worldwide
-
Requires cold chain handling for stability
DYSPORT® 300u – FAQ (Based on Google SERP)
How many units of DYSPORT® equal Botox®?
The general conversion ratio is 2.5 to 3 units of DYSPORT® = 1 unit of Botox®, though this varies by use and patient.
How long does DYSPORT® last?
Results typically last 3 to 4 months, similar to Botox®.
When will I see results from DYSPORT®?
Most patients notice results within 2–3 days, with full effect in 7–14 days.
Can DYSPORT® be used for the same areas as Botox®?
Yes. It’s approved for glabellar lines, cervical dystonia, and other muscle conditions, often used as a Botox alternative.
Is DYSPORT® safe for long-term use?
Yes. Clinical data support safe repeated use with consistent efficacy over multiple injection cycles.
What’s the difference between DYSPORT® and Botox®?
DYSPORT® diffuses more broadly, which may benefit larger treatment areas. Botox® may stay more localized.
Can children receive DYSPORT®?
Yes, for specific conditions such as lower limb spasticity in cerebral palsy, for children aged 2 and older.